207 related articles for article (PubMed ID: 32400873)
21. High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia.
Mu D; Long S; Guo L; Liu W
Technol Cancer Res Treat; 2021; 20():15330338211065877. PubMed ID: 34894858
[No Abstract] [Full Text] [Related]
22. SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.
Yue C; Xie S; Zhong J; Zhao H; Lin Z; Zhang L; Xu B; Luo Y
Sci Rep; 2021 Aug; 11(1):17012. PubMed ID: 34426610
[TBL] [Abstract][Full Text] [Related]
23. CTSB Knockdown Inhibits Proliferation and Tumorigenesis in HL-60 Cells.
Peng S; Yang Q; Li H; Pan Y; Wang J; Hu P; Zhang N
Int J Med Sci; 2021; 18(6):1484-1491. PubMed ID: 33628106
[No Abstract] [Full Text] [Related]
24. TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients.
Liu H; Chen P; Yang YL; Zhu KW; Wang T; Tang L; Liu YL; Cao S; Zhou G; Zeng H; Zhao XL; Zhang W; Chen XP
Eur J Pharmacol; 2021 Mar; 895():173894. PubMed ID: 33476656
[TBL] [Abstract][Full Text] [Related]
25. The Role of the
Chen SL; Qin ZY; Hu F; Wang Y; Dai YJ; Liang Y
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31426381
[TBL] [Abstract][Full Text] [Related]
26. SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.
Deng A; Ning Q; Zhou L; Liang Y
Sci Rep; 2016 Jun; 6():27694. PubMed ID: 27291931
[TBL] [Abstract][Full Text] [Related]
27. Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients.
Marcel V; Catez F; Berger CM; Perrial E; Plesa A; Thomas X; Mattei E; Hayette S; Saintigny P; Bouvet P; Diaz JJ; Dumontet C
PLoS One; 2017; 12(1):e0170160. PubMed ID: 28103300
[TBL] [Abstract][Full Text] [Related]
28. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
29. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
30. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
31. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.
Xu S; Li X; Zhang J; Chen J
PLoS One; 2015; 10(8):e0135981. PubMed ID: 26309131
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia.
Xu X; Sun R; Li Y; Wang J; Zhang M; Xiong X; Xie D; Jin X; Zhao M
BMC Med Genomics; 2023 May; 16(1):117. PubMed ID: 37237254
[TBL] [Abstract][Full Text] [Related]
35. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
[TBL] [Abstract][Full Text] [Related]
36. High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia.
Li J; Ge Z
BMC Cancer; 2021 Apr; 21(1):475. PubMed ID: 33926391
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
38. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
39. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
40. Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
Guo Z; Guo D; Kong D; Bian S; Zhao L; Li Q; Lin L; Hao J; Sun L; Li Y
Mol Biol Rep; 2023 Oct; 50(10):8445-8457. PubMed ID: 37632633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
